CSIMarket Company Name, Ticker, Suppliers, else..
 
Fate Therapeutics Inc   (NASDAQ: FATE)
 

Fate Therapeutics Inc's Suppliers Performance

FATE's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
FATE Costs vs Sales of Suppliers Growth

• More on FATE Suppliers






Fate Therapeutics Inc's Comment on Supply Chain


The company utilizes various suppliers, including sole source manufacturers, but currently lacks long-term supply agreements for certain key components of its iPSC-derived cell product candidates. It operates a cGMP-compliant manufacturing facility in San Diego, California, specifically designed for producing off-the-shelf cell product candidates from clonal master iPSC lines. This facility is licensed by the State of California Department of Health Services, Food and Drug Branch. Additionally, the company contracts with third parties, such as medical center cell therapy facilities and contract manufacturing organizations (CMOs), to conduct some manufacturing activities for clinical investigations and plans to maintain these arrangements.

Fate Therapeutics Inc's Comment on Supply Chain


The company utilizes various suppliers, including sole source manufacturers, but currently lacks long-term supply agreements for certain key components of its iPSC-derived cell product candidates. It operates a cGMP-compliant manufacturing facility in San Diego, California, specifically designed for producing off-the-shelf cell product candidates from clonal master iPSC lines. This facility is licensed by the State of California Department of Health Services, Food and Drug Branch. Additionally, the company contracts with third parties, such as medical center cell therapy facilities and contract manufacturing organizations (CMOs), to conduct some manufacturing activities for clinical investigations and plans to maintain these arrangements.







FATE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Fate Therapeutics Inc 279.92 6.49 -126.00 161
SUBTOTAL 0.00 0.00 0.00 -


Sources: Fate Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Fate Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.